EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer

Yongyin He, Bin Xiao, Ting Lei, Junfeng Xuan, Yi Zhu, Zhenzhan Kuang, Jiahui Liu, Jia He, Linhai Li, Zhaohui Sun

Gene · 2023-04 · 860 · 147227

DOI: 10.1016/j.gene.2023.147227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene, 2023-04. Verfasst von Yongyin He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA, 510010 Guangzhou, Guangdong, China; Department of Laboratory …. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China-Guangdong Joint Fund, China People's Liberation Army General Logistics Department, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Circulating long noncoding RNAs (lncRNAs) have been reported to serve as biomarkers for cancer diagnosis. Here, we identified the clinical diagnostic value and biological function of lncRNA T376626 in triple-negative breast cancer (TNBC). METHOD: A genome-wide lncRNA microarray was used to screen promising serum-based lncRNA biomarkers. The expression of candidate serum lncRNAs was validated in 282 breast cancer (BC) patients and 78 healthy subjects. The diagnostic value of serum lncRNA T376626 was determined by receiver operating characteristic (ROC) curve. RNA fluorescent in situ hybridization (FISH) and RNAScope ISH assays were conducted to examine the expression and localization of lncRNA T376626 in TNBC cells and BC tissues. Kaplan-Meier analysis was conducted to evaluate the relationship between lncRNA T376626 and BC patients' overall survival (OS) rate. CCK-8, colony-forming, wound healing and Transwell assays were performed to investigate the biological function of lncRNA T376626 on cell proliferation, migration, and invasion in two TNBC cell lines. Cell apoptosis-, cell cycle- and epithelial-mesenchymal transition (EMT)-related biomarkers were quantified by western blots. The lncRNA T376626 binding proteins were screened and identified by RNA pulldown. RESULTS: LncRNA T376626 level was significantly higher in TNBC serums and tissues. Higher levels of lncRNA T376626 were positively associated with a higher pathological differentiation stage, more aggressive molecular subtype, and poor prognosis in BC and TNBC patients. The area under the curve (AUC) of serum lncRNA T376626 was 0.842. Overexpression (Knockdown) of lncRNA T376626 significantly promoted (inhibited) TNBC cell proliferation, migration, and invasion, possibly by regulating several cell cycle, cell apoptosis and EMT biomarkers. LAMC2 were identified as lncRNA T376626-binding proteins. LAMC2 facilitated TNBC proliferation and metastasis through lncRNA T376626. CONCLUSIONS: LncRNA T376626 may serve as a TNBC serum-based diagnostic and prognostic biomarker and play an oncogenic role in TNBC progression through binding to LAMC2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsRNA, Long NoncodingMicroRNAsHumansIn Situ Hybridization, FluorescenceCell ProliferationBiomarkers, TumorCell Line, TumorGene Expression Regulation, NeoplasticCell MovementLaminin

Stichwörter der Autor:innen

Circulating lncRNAsDiagnosisMicroarrayPrognosisTriple-negative breast cancer

Substanzen

RNA, Long NoncodingBiomarkers, TumorMicroRNAsLAMC2 protein, humanLaminin

Autor:innen und Institutionen

  • Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA, 510010 Guangzhou, Guangdong, China; Department of Laboratory Medicine, The Affiliated Brain Hospital of Guangzhou Medical Universit…
  • Department of Laboratory Medicine, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, 511518 Qingyuan, Guangdong, China. Electronic address: xiaobin2518@163.com.
  • Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-sen University, 519000 Zhuhai, Guangdong, China.
  • Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA, 510010 Guangzhou, Guangdong, China.
  • Department of Clinical Laboratory, South China Hospital of Shenzhen University, 518111 Shenzhen, Guangdong, China.
  • Guangzhou Center for Disease Control and Prevention, 510440 Guangzhou, Guangdong, China.

Förderung

  • National Natural Science Foundation of China-Guangdong Joint Fund
  • China People's Liberation Army General Logistics Department
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

He, Y., Xiao, B., Lei, T., Xuan, J., Zhu, Y., Kuang, Z., Liu, J., He, J., Li, L., & Sun, Z. (2023). LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer. Gene, 860, 147227. https://doi.org/10.1016/j.gene.2023.147227

Vancouver

He Y, Xiao B, Lei T, Xuan J, Zhu Y, Kuang Z, et al. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer. Gene. 2023;860:147227. doi:10.1016/j.gene.2023.147227

BibTeX
@article{He2023,
  author = {He, Yongyin and Xiao, Bin and Lei, Ting and Xuan, Junfeng and Zhu, Yi and Kuang, Zhenzhan and Liu, Jiahui and He, Jia and Li, Linhai and Sun, Zhaohui},
  title = {LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer},
  journal = {Gene},
  year = {2023},
  volume = {860},
  pages = {147227},
  doi = {10.1016/j.gene.2023.147227}
}
Kostenlos starten →